Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

A man crosses the Central Intelligence Agency seal. Photo: SAUL LOEB/AFP/Getty Images

A former CIA officer was found guilty of espionage, on behalf of China, and lying to the FBI about communication with Chinese officials, the New York Times reports. The officer, Kevin Mallory, faces life in prison following the verdict.

The intrigue: Per the times, the prosecution called his story "totally and completely absurd," explaining that he "selectively disclosed his contacts in order to have a potential defense in case federal investigators caught on to his true plan: to trade American secrets for cash." However, Mallory’s lawyers persistently denied the charges claiming that he is "a former C.I.A. clandestine officer and a private consultant, is a patriot who planned to use his recruitment to lure Chinese intelligence handlers into the C.I.A.'s grasp."

The gritty details: Mallory was contacted by a Chinese headhunter in early 2017 to do contracting work for a networking site. The Times details that Mallory, who is fluent in Mandarin Chinese, "was passed to a Chinese intelligence operative working for a think tank who wanted him to become an informant." He then traveled to Shanghai, "had covert communications with the operative on a Chinese-provided phone and passed information — including an unclassified white paper on American intelligence policy — to his handlers," per the Times, citing authorities.

  • "But Chinese attempts to protect the contents of the phone from prying eyes failed because of an apparent technical problem," per the Times. Adding that "the F.B.I. was able to analyze it and found a handwritten index describing eight documents. Four of the documents listed in the index were found on the phone, with three containing classified information."

One key twist: He reportedly "told the F.B.I. and the C.I.A. parts of the story and provided his phone to agents. This was evidence that Mr. Mallory was not a spy, his lawyers said."

What they're saying: G. Zachary Terwilliger, the United States attorney for the Eastern District of Virginia told the Times: "There are few crimes in this country more serious than espionage... This office has a long history of holding those accountable who betray their country and try and profit off of classified information."

Go deeper

10 hours ago - Politics & Policy

Biden explains justification for Syria strike in letter to Congress

Photo: Chris Kleponis/CNP/Bloomberg via Getty Images

President Biden told congressional leadership in a letter Saturday that this week's airstrike against facilities in Syria linked to Iranian-backed militia groups was consistent with the U.S. right to self-defense.

Why it matters: Some Democrats, including Sens. Tim Kaine (D-Va.) and Chris Murphy (D-Conn.) and Rep. Ro Khanna (D-Calif.), have criticized the Biden administration for the strike and demanded a briefing.

11 hours ago - Health

FDA authorizes Johnson & Johnson's one-shot COVID-19 vaccine for emergency use

Photo: Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Saturday issued an emergency use authorization for Johnson & Johnson's one-shot coronavirus vaccine.

Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech's two-shot vaccines.

Updated 12 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios